Raymond James Financial Services Advisors Inc. grew its position in shares of CME Group Inc. (NASDAQ:CME) by 7.6% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 369,133 shares of the financial services provider’s stock after purchasing an additional 26,047 shares during the quarter. Raymond James Financial Services Advisors Inc. owned about 0.11% of CME Group worth $50,090,000 as of its most recent SEC filing.
A number of other institutional investors have also recently added to or reduced their stakes in CME. Fiduciary Trust Co. bought a new stake in shares of CME Group in the 2nd quarter valued at $105,000. Quadrant Capital Group LLC increased its stake in shares of CME Group by 13.6% in the 2nd quarter. Quadrant Capital Group LLC now owns 944 shares of the financial services provider’s stock valued at $111,000 after acquiring an additional 113 shares in the last quarter. San Francisco Sentry Investment Group CA bought a new stake in shares of CME Group in the 2nd quarter valued at $129,000. Whittier Trust Co. increased its stake in shares of CME Group by 2.6% in the 2nd quarter. Whittier Trust Co. now owns 1,057 shares of the financial services provider’s stock valued at $133,000 after acquiring an additional 27 shares in the last quarter. Finally, People s United Financial Inc. increased its stake in shares of CME Group by 11.5% in the 2nd quarter. People s United Financial Inc. now owns 1,063 shares of the financial services provider’s stock valued at $133,000 after acquiring an additional 110 shares in the last quarter. Hedge funds and other institutional investors own 82.63% of the company’s stock.
In other CME Group news, Director Daniel R. Glickman sold 850 shares of CME Group stock in a transaction on Monday, August 28th. The shares were sold at an average price of $126.65, for a total transaction of $107,652.50. Following the transaction, the director now directly owns 13,799 shares of the company’s stock, valued at approximately $1,747,643.35. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO John W. Pietrowicz sold 5,175 shares of CME Group stock in a transaction on Thursday, November 2nd. The stock was sold at an average price of $139.70, for a total transaction of $722,947.50. The disclosure for this sale can be found here. Insiders have sold a total of 11,339 shares of company stock valued at $1,548,086 in the last 90 days. 0.57% of the stock is currently owned by company insiders.
WARNING: This piece was posted by StockNewsTimes and is the property of of StockNewsTimes. If you are viewing this piece on another site, it was copied illegally and republished in violation of U.S. & international copyright law. The correct version of this piece can be viewed at https://stocknewstimes.com/2017/11/17/raymond-james-financial-services-advisors-inc-has-50-09-million-holdings-in-cme-group-inc-cme.html.
Shares of CME Group Inc. (CME) opened at $140.09 on Friday. The company has a market cap of $47,364.19, a price-to-earnings ratio of 29.22, a price-to-earnings-growth ratio of 2.87 and a beta of 0.71. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.05 and a current ratio of 1.05. CME Group Inc. has a one year low of $111.19 and a one year high of $141.44.
CME Group (NASDAQ:CME) last announced its quarterly earnings results on Thursday, October 26th. The financial services provider reported $1.19 EPS for the quarter, beating the Zacks’ consensus estimate of $1.16 by $0.03. The business had revenue of $890.80 million during the quarter, compared to analyst estimates of $890.22 million. CME Group had a net margin of 40.94% and a return on equity of 7.89%. CME Group’s quarterly revenue was up 5.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.05 EPS. equities research analysts forecast that CME Group Inc. will post 4.78 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 27th. Shareholders of record on Friday, December 8th will be paid a dividend of $0.66 per share. The ex-dividend date of this dividend is Thursday, December 7th. This represents a $2.64 dividend on an annualized basis and a yield of 1.88%. CME Group’s dividend payout ratio (DPR) is presently 59.86%.
Several research firms have recently weighed in on CME. BidaskClub upgraded shares of CME Group from a “hold” rating to a “buy” rating in a research note on Friday, August 18th. Citigroup Inc. lifted their price objective on shares of CME Group from $138.00 to $155.00 and gave the company a “buy” rating in a research note on Thursday, October 19th. Barclays PLC began coverage on shares of CME Group in a research note on Friday, September 8th. They issued an “overweight” rating and a $139.00 price objective for the company. Wells Fargo & Company lifted their price objective on shares of CME Group from $130.00 to $145.00 and gave the company a “market perform” rating in a research note on Wednesday, October 4th. Finally, Keefe, Bruyette & Woods reiterated a “hold” rating and issued a $133.00 price objective on shares of CME Group in a research note on Thursday, September 21st. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and seven have assigned a buy rating to the company. The stock has a consensus rating of “Buy” and an average price target of $141.75.
CME Group Company Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.